[Development of physical dependence on nicotine and endogenous opioid system--participation of α7 nicotinic acetylcholine receptor]
- PMID: 25651617
[Development of physical dependence on nicotine and endogenous opioid system--participation of α7 nicotinic acetylcholine receptor]
Abstract
Nicotine (NIC) regulates various cellular functions acting on the nicotinic acetylcholine receptor (nAChR). And nAChR consists of ligand-gated cation channels with pentameric structure and composed of α and β subunits. In the central nervous system, α 4 β 2 and α 7 nAChRs are the most abundantly expressed as nAChR subtypes. There are several lines of evidence indicating that systemic administration of NIC elicits the release of endogenous opioids, such as, endorphins, enkephalins and dynorphins, in the brain. NIC exerts numerous acute effects, for example, antinociceptive effects and the activating effects of the hypothalamic-pituitary-adrenal (HPA) axis. In these effects, NIC-induced antinociception, but not HPA axis activation, was inhibited by opioid receptor antagonist, naloxone (NLX), and was also suppressed in morphine tolerated mice, indicating the participation of the endogenous opioid system in NIC-induced antinociception, but not HPA axis activation. Moreover, NIC-induced antinociception was antagonized by both α 4 β 2 and α 7 nAChR antagonists, while NIC-induced HPA axis activation was antagonized by α 4 β 2 nAChR antagonist, but not by α 7 nAChR antagonist. These results suggest that the endogenous opioid system may not be located on the downstream of α 4 β 2 nAChR. On the other hand, NIC has substantial physical dependence liability. NLX elicits NIC withdrawal after repeated NIC administration evaluated by corticosterone increase as a withdrawal sign, and NLX-precipitated NIC withdrawal is inhibited by concomitant administration of other opioid receptor antagonist, naltrexone, indicating the participation of endogenous opioid system in the development of physical dependence on NIC. NLX-precipitated NIC withdrawal was also inhibited by concomitant administration of an α 7 nAChR antagonist, but not an α 4 β 2 nAChR antagonist. Taken together, these findings suggest that the endogenous opioid system may be located on the downstream of α 7 nAChR and participates in the development of physical dependence on NIC.
Similar articles
-
Nicotine effects and the endogenous opioid system.J Pharmacol Sci. 2014;125(2):117-24. doi: 10.1254/jphs.14r03cp. Epub 2014 May 31. J Pharmacol Sci. 2014. PMID: 24882143 Review.
-
Possible involvement of endogenous opioid system located downstream of α7 nicotinic acetylcholine receptor in mice with physical dependence on nicotine.J Pharmacol Sci. 2014;124(1):47-53. doi: 10.1254/jphs.13172fp. Epub 2013 Dec 21. J Pharmacol Sci. 2014. PMID: 24366190
-
Pharmacological relationship between nicotinic and opioid systems in analgesia and corticosterone elevation.Life Sci. 2011 Dec 19;89(25-26):956-61. doi: 10.1016/j.lfs.2011.10.004. Epub 2011 Oct 20. Life Sci. 2011. PMID: 22036617
-
Involvement of spinal Met-enkephalin in nicotine-induced antinociception in mice.Brain Res. 2008 Jan 16;1189:70-7. doi: 10.1016/j.brainres.2007.10.086. Epub 2007 Nov 7. Brain Res. 2008. PMID: 18048009
-
Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system.Neurosci Biobehav Rev. 2010 Nov;35(2):220-31. doi: 10.1016/j.neubiorev.2010.02.006. Epub 2010 Feb 16. Neurosci Biobehav Rev. 2010. PMID: 20170672 Free PMC article. Review.
Cited by
-
Determining population stratification and subgroup effects in association studies of rare genetic variants for nicotine dependence.Psychiatr Genet. 2019 Aug;29(4):111-119. doi: 10.1097/YPG.0000000000000227. Psychiatr Genet. 2019. PMID: 31033776 Free PMC article.